Development Level

Tbio 10 | 11,651
Tchem 2 | 1,388

IMPC Phenotype

abnormal kidney morphology 1 | 65
abnormal seminal vesicle morph... 1 | 114
decreased body length 1 | 101
decreased heart weight 1 | 27
decreased vertical activity 1 | 208
increased body length 1 | 32

Disease

psoriasis 6 | 6,694
Atherosclerosis 5 | 291
osteosarcoma 5 | 7,950
Carcinoma 4 | 11,493
Coronary artery disease 4 | 268
Lipid metabolism disorder 4 | 114
Liver Cirrhosis, Experimental 4 | 769
Obesity 4 | 678
diabetes mellitus 4 | 1,728
invasive ductal carcinoma 4 | 2,951
ovarian cancer 4 | 8,520
pancreatic ductal adenocarcinoma liver metastasis 4 | 1,962
Carcinoma, Hepatocellular 3 | 228
Chemical and Drug Induced Liver Injury 3 | 195
Cholestasis 3 | 155
Hepatomegaly 3 | 285
Liver Neoplasms, Experimental 3 | 59
Liver carcinoma 3 | 240
active Crohn's disease 3 | 922
ductal carcinoma in situ 3 | 1,745
lung cancer 3 | 4,740
pancreatic cancer 3 | 2,398
primitive neuroectodermal tumor 3 | 3,035
Breast cancer 2 | 3,578
Cardiovascular system disease 2 | 246
Drug Eruptions 2 | 18
Kidney Diseases 2 | 114
Kidney Failure 2 | 111
Pancreatitis 2 | 123
Pediatric Obesity 2 | 4
Schizophrenia 2 | 1,160
Splenomegaly 2 | 190
active ulcerative colitis 2 | 764
adrenocortical carcinoma 2 | 1,428
adult high grade glioma 2 | 3,801
astrocytic glioma 2 | 2,597
atypical teratoid / rhabdoid tumor 2 | 5,112
breast carcinoma 2 | 1,638
dermatomyositis 2 | 966
gastric carcinoma 2 | 807
group 4 medulloblastoma 2 | 1,855
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,989
malignant mesothelioma 2 | 3,232
medulloblastoma, large-cell 2 | 6,241
oligodendroglioma 2 | 2,850
Acute Lung Injury 1 | 22
Adenocarcinoma of lung (disorder) 1 | 60
Amyloidosis 1 | 67
Angle class 2 malocclusion 1 | 57
Angle class 3 malocclusion 1 | 57
Bicuspid aortic valve 1 | 16
Bladder Diverticulum 1 | 15
Bunion 1 | 26
Congenital hypoplasia of kidney 1 | 32
Decreased projection of midface 1 | 105
Decreased size of teeth 1 | 62
Decreased width of tooth 1 | 59
Diabetic Cardiomyopathies 1 | 10
Edema 1 | 81
Full lower lip 1 | 64
Hallux Valgus 1 | 26
Hematuria 1 | 36
Hemiplegia and hemiparesis 1 | 38
High density lipoprotein decreased 1 | 10
Hoarseness 1 | 31
Hyperacusis 1 | 11
Hyperglycemia 1 | 137
Hypertriglyceridemia 1 | 17
Hypertriglyceridemia result 1 | 37
Hypoalphalipoproteinemias 1 | 10
Hypotrophic midface 1 | 105
Idiopathic scoliosis 1 | 31
Joint laxity 1 | 54
Kidney Failure, Chronic 1 | 46
Kyphoscoliosis deformity of spine 1 | 60
Malocclusion 1 | 57
Microdontia (disorder) 1 | 59
Micronychia (disorder) 1 | 24
Midface retrusion 1 | 105
Mitral Valve Prolapse Syndrome 1 | 39
Mitral regurgitation, mild 1 | 32
Nephrotic Syndrome 1 | 78
Open mouth 1 | 45
Open-angle glaucoma 1 | 27
Pelvic kidney 1 | 10
Periorbital fullness 1 | 9
Peripheral pulmonary artery stenosis 1 | 14
Phonophobia 1 | 11
Premature canities 1 | 24
Prominent lower lip 1 | 64
Pulmonary emphysema 1 | 48
Retinitis pigmentosa 25 1 | 9
Short bowel syndrome 1 | 16
Sloping shoulders 1 | 21
Small midface 1 | 105
Soft skin 1 | 17
Urethral Stricture 1 | 18
Velvety skin 1 | 17
Vesico-Ureteral Reflux 1 | 33
Williams Syndrome 1 | 10

Tissue

Digestive Tract 12 | 17,369
Endocrine System 12 | 18,159
Female tissues 12 | 17,400
Liver and Pancreas 12 | 16,750
Skin and soft tissues 12 | 17,230
Blood and immune system 11 | 16,909
Male tissues 11 | 17,142
Respiratory system 11 | 16,393
Urinary Tract 11 | 16,678
Cardiovascular System 10 | 15,192
Nervous System 10 | 16,725

Target Family

Non-IDG 7 | 12,091
Nuclear Receptor 2 | 48
Enzyme 1 | 4,145
Transcription Factor 1 | 1,400
Transporter 1 | 473

GO Process

positive regulation of fatty a... 12 | 12
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Apolipoprotein C-II APOC2 Tbio Non-IDG -2.51086 342.7 22
Apolipoprotein A-I APOA1 Tbio Non-IDG -3.62534 3592.8 1151
Mid1-interacting protein 1 MID1IP1 Tbio Non-IDG -0.74560 6.48 97
Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 LPGAT1 Tbio Enzyme -1.16212 13.2 56
Elongation of very long chain fatty acids protein 5 ELOVL5 Tbio Non-IDG -1.90493 83.7 237
Apolipoprotein A-V APOA5 Tbio Non-IDG -2.58826 425.0 481
Carbohydrate-responsive element-binding protein MLXIPL Tbio Transcription Factor -2.29554 206.7 235
Regucalcin RGN Tbio Non-IDG -2.61474 478.2 85
Solute carrier family 45 member 3 SLC45A3 Tbio Transporter -1.57222 35.9 141
Apolipoprotein A-IV APOA4 Tbio Non-IDG -2.45218 211.8 324